logo image
search icon
Cell Free RNA Isolation & Extraction Kits Market

Cell Free RNA Isolation & Extraction Kits Market Size, Share & Trends Analysis Report By Applications (Oncology, Prenatal Screening, Metabolic Disorders) And End-Use (Hospitals & Clinics, Pharmaceutical & Biotechnology Companies), By Region, And Segment Forecasts, 2023-2031

Report ID : 1572 | Published : 2023-03-09 | Pages: 180 | Format: PDF/EXCEL

The Global Cell Free RNA Isolation & Extraction Kits Market Size is valued at 37.18 million in 2022 and is predicted to reach 122.23 million by the year 2031 at an 14.43% CAGR during the forecast period for 2023-2031.

RNA extraction kits isolate the RNA from any cell, which can be extracted from an animal, a bacterium, or a plant. These extractions are mostly used for RNA profiling different species to comprehend them better and, in certain cases, to identify the unidentified organism. Technological developments, the introduction of new products by major market participants, and increasing cancer incidence worldwide may also aid the market's expansion.

Cell Free RNA Isolation & Extraction Kits Market

A decline in patient turnout for testing as a result of COVID-19 has had an impact on the diagnostic tests for other diseases and medical disorders in hospitals and other clinical diagnostics establishments. However, the high COVID-19 infection rate and important local company research initiatives raising rates of various cancer kinds and an increase in cases of prenatal problems are the main factors driving the market development.

The market for cell-free RNA isolation and extraction kits is well-established. It plays a significant role in medical decision-making by assisting in gathering data for disseminating various treatments, underscoring its importance in healthcare. A growing elderly population base, extensive research & innovation, patient population knowledge of non-invasive and minimally invasive procedures, increased government funding, and technical improvements are further drivers boosting the market's growth. 

Recent Developments:

  • In February 2022- A technological commercialization partnership agreement between Zinexts Life Science Corp. and JBS Science, Inc. is signed, allowing Zinexts to produce and market JBS nucleic separation kits, including cfDNA and RNA isolation kits. Access to JBS NA Zinexts' isolation automation systems and equipment will be made simpler by this license agreement.
  • In October 2020- Cells to Pure DNA Low Input Kit, a DNA extraction kit for researchers dealing with constrained biological material was introduced by Purigen Biosystems Inc

Competitive Landscape:

Global cell-free RNA isolation & extraction kits market players are:

  • Aline Biosciences
  • Apostle Inc. (Apostle Sciences)
  • Danagen-Bioted, S.L.
  • Hoffmann-La Roche Ltd.
  • JBS Science Inc.
  • Norgen Biotek Corp
  • PerkinElmer, Inc.
  • Promega Corporation
  • QIAGEN N.V.
  • Streck, Inc.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • Zymo Research Corporation

Market Segmentation:

The cell-free RNA isolation & extraction kits market is segmented on the applications and end-use. The market is segmented based on applications: oncology, prenatal screening, metabolic disorders, and others. Based on end-use, the market is further segmented into hospitals & clinics, pharmaceutical & biotechnology companies, and others.

Based On End Users, The Parental Screening Segment Is A Major Contributor To The Cell-Free RNA Isolation & Extraction Kits Market

The market's leading segment is parental screening. The use of non-invasive methods like cell-free RNA, which aids in predicting prenatal problems, is advancing quickly. Cell-free RNA can be used to describe and predict prenatal problems such as intrauterine growth restriction (IUGR), preeclampsia, and spontaneous preterm birth (PTB) (cf RNA). Thus, the rise in demand for cell-free RNA isolation and extraction kits is boosting the market demand due to the rise in women experiencing prenatal problems.

The Hospital & Clinics Segment Witnessed Growth At A Rapid Rate

Hospitals grabbed the highest revenue share, and it is anticipated that they will continue to hold that position during the anticipated time due to the growing need for precise and early disease diagnosis. Techniques for isolating and purifying  RNA are thought to be efficient screening tools for hereditary illnesses such as sickle cell anemia, hemophilia A, and Tay-Sachs disease. Therefore, the availability of such effective technologies at moderate to cheap prices will likely improve the adoption rate of these technologies in medical facilities and hospitals.

The North American Cell-Free RNA Isolation & Extraction Kits Market Holds A Significant Regional Revenue Share

The North American cell-free RNA isolation & extraction kits Industry is expected to register the highest market share in revenue soon. The main factor driving market expansion in the area is the presence of established companies and their work on creating technologically cutting-edge fast purification and isolation systems. Additionally, the increasing financing initiatives for biotechnology research are accelerating the market's growth.

In addition, Asia Pacific is projected to grow rapidly in the global cell-free RNA isolation & extraction kits business. Rising economic growth, substantial life sciences research, an increasing patient population, supportive government measures, and numerous creative biotech companies in the area are all factors causing the market in the region to flourish.

Cell Free RNA Isolation & Extraction Kits Market Report Scope:

Report Attribute

Specifications

Market size value in 2022

USD 37.18 Mn

Revenue forecast in 2031

USD 122.23 Mn

Growth rate CAGR

CAGR of 14.43% from 2023 to 2031

Quantitative units

Representation of revenue in US$ Million, and CAGR from 2023 to 2031

Historic Year

2019 to 2022

Forecast Year

2023-2031

Report coverage

The forecast of revenue, the position of the company, the competitive market statistics, growth prospects, and trends

Segments covered

Applications And End-Use

Regional scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia

Competitive Landscape

F.Hoffmann-La Roche AG, JBS Science Inc., Aline Biosciences, Apostle Inc. (Apostle Sciences), Danagen-Bioted, S.L., Norgen Biotek Corp., PerkinElmer, Inc., Promega Corporation, QIAGEN N.V., and Thermo Fisher Scientific Inc.

Customization scope

Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing and available payment methods

Explore pricing alternatives that are customized to your particular study requirements.

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Cell Free RNA Isolation & Extraction Kits Market Snapshot

Chapter 4. Global Cell Free RNA Isolation & Extraction Kits Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: by Application Estimates & Trend Analysis
5.1. by Application & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Application:

5.2.1. Oncology
5.2.2. Prenatal Screening
5.2.3. Metabolic Disorders
5.2.4. Others

Chapter 6. Market Segmentation 2: by End-users Estimates & Trend Analysis
6.1. by End-users & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End-users:

6.2.1. Hospitals & Clinics
6.2.2. Pharmaceutical & Biotechnology Companies
6.2.3. Others

Chapter 7. Cell Free RNA Isolation & Extraction Kits Market Segmentation 3: Regional Estimates & Trend Analysis

7.1. North America

7.1.1. North America Cell Free RNA Isolation & Extraction Kits Market Revenue (US$ Million) Estimates and Forecasts by Application, 2023-2031
7.1.2. North America Cell Free RNA Isolation & Extraction Kits Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2023-2031
7.1.3. North America Cell Free RNA Isolation & Extraction Kits Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031

7.2. Europe

7.2.1. Europe Cell Free RNA Isolation & Extraction Kits Market Revenue (US$ Million) Estimates and Forecasts by Application, 2023-2031
7.2.2. Europe Cell Free RNA Isolation & Extraction Kits Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2023-2031
7.2.3. Europe Cell Free RNA Isolation & Extraction Kits Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031

7.3. Asia Pacific

7.3.1. Asia Pacific Cell Free RNA Isolation & Extraction Kits Market Revenue (US$ Million) Estimates and Forecasts by Application, 2023-2031
7.3.2. Asia Pacific Cell Free RNA Isolation & Extraction Kits Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2023-2031
7.3.3. Asia Pacific Cell Free RNA Isolation & Extraction Kits Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031

7.4. Latin America

7.4.1. Latin America Cell Free RNA Isolation & Extraction Kits Market Revenue (US$ Million) Estimates and Forecasts by Application, 2023-2031
7.4.2. Latin America Cell Free RNA Isolation & Extraction Kits Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2023-2031
7.4.3. Latin America Cell Free RNA Isolation & Extraction Kits Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031

7.5. Middle East & Africa

7.5.1. Middle East & Africa Cell Free RNA Isolation & Extraction Kits Market Revenue (US$ Million) Estimates and Forecasts by Application, 2023-2031
7.5.2. Middle East & Africa Cell Free RNA Isolation & Extraction Kits Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2023-2031
7.5.3. Middle East & Africa Cell Free RNA Isolation & Extraction Kits Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031

Chapter 8. Competitive Landscape

8.1. Major Mergers and Acquisitions/Strategic Alliances

8.2. Company Profiles


8.2.1. Aline Biosciences
8.2.2. Apostle Inc. (Apostle Sciences)
8.2.3. Danagen-Bioted, S.L.
8.2.4. F. Hoffmann-La Roche Ltd.
8.2.5. JBS Science Inc.
8.2.6. Norgen Biotek Corp
8.2.7. PerkinElmer, Inc.
8.2.8. Promega Corporation
8.2.9. QIAGEN N.V.
8.2.10. Streck, Inc.
8.2.11. Takara Bio Inc.
8.2.12. Thermo Fisher Scientific Inc.
8.2.13. Zymo Research Corporation
8.2.14. Other Prominent Players

Segmentation of Cell Free RNA Isolation & Extraction Kits Market-

Cell Free RNA Isolation & Extraction Kits Market By Application-

  • Oncology
  • Prenatal Screening
  • Metabolic Disorders
  • Others

Cell Free RNA Isolation & Extraction Kits Market

Cell Free RNA Isolation & Extraction Kits Market By End User-

  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies 
  • Others

Cell Free RNA Isolation & Extraction Kits Market By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

How big is the Cell Free RNA Isolation & Extraction Kits Market?

Cell Free RNA Isolation & Extraction Kits Market expected to grow at 14.43% CAGR during the forecast period for 2023-2031

F.Hoffmann-La Roche AG, JBS Science Inc., Aline Biosciences, Apostle Inc. (Apostle Sciences), Danagen-Bioted, S.L., Norgen Biotek Corp., PerkinElmer,

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Biotechnology

Select Licence Type
$4456
$7786
$10000
$1200
Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach